organization · Reporting owner
MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NEUROONE MEDICAL TECHNOLOGIES Corp
Report date April 03, 2019 · Filed April 04, 2019
Section 16 reporting ended · disclosed 2019-04-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, Par value $0.001SEC Table I · non-derivative | Direct | 572,846 |
Reported balance
After 2019-04-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-04-03 · Other · Disposed 287,130 · Balance 572,846 F1: The Reporting Person transferred the shares to several individuals in satisfaction of certain contractual obligations. The price of $4.25 per share represents the recent market price of a share of common stock at the time of transfer. F2: Mayo Clinic, a Minnesota corporation ("Mayo"), is the controlling corporation of the Reporting Person and is referenced here solely due to its control of the Reporting Person. Mayo disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that Mayo is the beneficial owner of the securities for purposes of Section 16 or any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person transferred the shares to several individuals in satisfaction of certain contractual obligations. The price of $4.25 per share represents the recent market price of a share of common stock at the time of transfer.
F2: Mayo Clinic, a Minnesota corporation ("Mayo"), is the controlling corporation of the Reporting Person and is referenced here solely due to its control of the Reporting Person. Mayo disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that Mayo is the beneficial owner of the securities for purposes of Section 16 or any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2019 Filed Apr 4, 2019 16:30 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | OtherCommon Stock, Par value $0.001 | 287,130 | $4.25 | $1,220,302.50 |
DisclosureSEC source: 0000899243-19-009986 · doc4.xml · nonDerivative · entry 1 MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH · CIK 0000897680 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572,846 F1 · kind: The Reporting Person transferred the shares to several individuals in satisfaction of certain contractual obligations. The price of $4.25 per share represents the recent market price of a share of common stock at the time of transfer. F1 · price: The Reporting Person transferred the shares to several individuals in satisfaction of certain contractual obligations. The price of $4.25 per share represents the recent market price of a share of common stock at the time of transfer. F2 · ownership.direct: Mayo Clinic, a Minnesota corporation ("Mayo"), is the controlling corporation of the Reporting Person and is referenced here solely due to its control of the Reporting Person. Mayo disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that Mayo is the beneficial owner of the securities for purposes of Section 16 or any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.